SOURCE BIOSCIENCE LIMITED
Get an alert when SOURCE BIOSCIENCE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-01-23 (in 8mo)
Last made up 2026-01-09
Watchouts
None on the register
Cash
£3M
-91.6% vs 2023
Net assets
£20M
-0.3% vs 2023
Employees
2
0% vs 2023
Profit before tax
-£187K
-100.9% vs 2023
Name history
Renamed 5 times since incorporation
- SOURCE BIOSCIENCE LIMITED 2017-08-08 → present
- SOURCE BIOSCIENCE PLC 2008-03-10 → 2017-08-08
- MEDICAL SOLUTIONS PLC 1999-08-23 → 2008-03-10
- TURNPYKE GROUP PLC 1993-10-29 → 1999-08-23
- W B INDUSTRIES PLC 1986-09-23 → 1993-10-29
- WEST BROMWICH SPRING PLC(THE) 1903-11-14 → 1986-09-23
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£6,000 | -£17,000 | |
| Profit before tax | £19,990,000 | -£187,000 | |
| Net profit | £19,990,000 | -£187,000 | |
| Cash | £31,071,000 | £2,623,000 | |
| Total assets less current liabilities | £24,027,000 | £20,223,000 | |
| Net assets | £20,283,000 | £20,223,000 | |
| Equity | £20,283,000 | £20,223,000 | |
| Average employees | 2 | 2 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -0.0% | -0.1% | |
| Current ratio | 0.58x | 0.26x | |
| Interest cover | -0.01x | -0.03x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements and have prepared detailed budgets and forecasts for the Company and its trading subsidiaries covering the period to 31 December 2026. The company has received confirmation of continued support from its ultimate parent company SourceBio International Limited for at least twelve months from the date of approval of these financial statements. Based on the forecast cash and operating profits forecast at the group level, the directors have a reasonable expectation that the company has adequate resources to continue operating and meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements.”
Group structure
- SOURCE BIOSCIENCE LIMITED · parent
- Source BioScience UK Limited 100%
- Source BioScience (Orchard Place) Limited 100%
- Select Pharma Laboratories Ltd. 100%
- Source BioScience (Cryobank) Limited 100%
- Fairfield Imaging Limited 100%
- Fairfield Telepathology Limited 100%
- Kinetic Imaging Limited 100%
- Cryobank Guarantor Limited 100%
- SourceBio International, Inc 100%
- Source Genomics Limited 100%
- LDPath Limited 100%
- Source BioScience Scotland Limited 100%
Significant events
- “The company made a loss for the year of £187,000 (2023: profit of £19,990,000) including dividend income of £Nil (2023: £5,531,000) and £158,000 (2023: £15,125,000) profit on the disposal of Source BioScience (Healthcare) Limited, along with its subsidiaries, Source Bioscience Ireland Limited, Source BioScience (Storage) Limited, Source BioScience Inc.”
- “The investment in group undertakings has been uplifted by £2,804,000 (2023: £2,294,000) due to an increase in the contingent consideration payable in relation to the acquisition of LD Path Limited.”
- “As at 31 December 2024, under the terms of the Source Bioscience UK Limited banking facilities established with Barclays Bank plc during 2022, the company was party to a bank guarantee along with certain other group companies. As at 31 December 2024 and the date of signing these financial statements £4,000,000 was drawn down in the year under the facility.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 44 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BARLOW, Amanda Louise | Director | 2023-09-27 | Aug 1973 | British |
| LECOQUE, Jay Charles | Director | 2016-11-24 | Nov 1962 | American |
Show 44 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ASH, Nicholas Watson, Dr | Secretary | 2006-08-31 | 2017-05-12 |
| ASTLE, Michael John | Secretary | 2017-05-12 | 2017-10-05 |
| CATER, Eric John | Secretary | 1998-12-14 | 2000-08-31 |
| GILLAMS, Charles Alfred Richard | Secretary | 1993-08-16 | 1993-10-04 |
| JOHNSTON, Neil Gerard, Dr | Secretary | 2005-01-14 | 2006-08-31 |
| LONGSTAFFE, Andrew David | Secretary | 2000-08-31 | 2005-01-18 |
| LUNN, Anthony John Mcgregor | Secretary | — | 1993-01-13 |
| PURDEN, Nigel Llewellyn | Secretary | 1993-10-04 | 1998-12-13 |
| ADAMS, Rodney Harry, Dr | Director | 2000-05-04 | 2003-01-21 |
| AGNEW, James Douglas | Director | 2017-04-27 | 2020-10-23 |
| ASH, Nicholas Watson, Dr | Director | 2006-08-31 | 2017-05-12 |
| BAKEWELL, Robert | Director | 2012-08-21 | 2014-09-04 |
| CATER, Eric John | Director | 1993-05-11 | 2000-08-31 |
| CHISHOLM, Iain Macdonald | Director | 2017-04-27 | 2018-01-02 |
| CLINCH, Noah, Dr | Director | 1999-08-23 | 2000-04-19 |
| ELLIS, Ian Ogilvie, Professor | Director | 2003-03-25 | 2004-12-21 |
| FODEN, Sue, Dr | Director | 2003-09-01 | 2015-08-31 |
| GIBBS, Somerset Bryan | Director | — | 1993-07-06 |
| GILLAMS, Charles Alfred Richard | Director | 1993-05-11 | 1999-02-04 |
| GRANDFIELD, Peter Barnet Whitworth | Director | — | 1994-06-08 |
| GREEN, Charles Alexander | Director | 1999-07-27 | 2006-08-31 |
| JACKSON-SMITH, Timothy David | Director | 2015-08-25 | 2016-09-15 |
| JOHNSTON, Neil Gerard, Dr | Director | 2005-01-14 | 2007-01-31 |
| KIRKHAM, David Michael | Director | 2021-06-16 | 2022-09-26 |
| LAMB, Ronald Hunter | Director | 1995-06-14 | 1996-07-31 |
| LEAVES, Nicholas Ivor, Dr. | Director | 2008-07-01 | 2017-05-12 |
| LIVERSIDGE, Pamela | Director | 2014-07-03 | 2016-09-15 |
| LONGSTAFFE, Andrew David | Director | 2000-05-04 | 2005-01-18 |
| MARLAND, Peter Greaves | Director | — | 1991-10-01 |
| MCDONALD, Anthony Michael | Director | 1999-08-23 | 2001-02-28 |
| METCALFE, Timothy Charles | Director | 2014-09-04 | 2017-05-12 |
| MITCHELL, Jonathan James | Director | — | 1993-07-09 |
| NOLAN, Trevor Frank | Director | 2018-01-09 | 2020-02-28 |
| PURDEN, Nigel Llewellyn | Director | 1995-05-15 | 1998-12-13 |
| RATCLIFFE, Anthony James | Director | 2020-11-17 | 2023-09-27 |
| ROBERTS, Gareth Gwyn, Professor Sir | Director | 1999-08-23 | 2007-02-01 |
| SEYMOUR, Donald Edwin | Director | 2000-06-21 | 2002-04-22 |
| SIKORA, Karol, Prof | Director | 2002-04-22 | 2008-03-10 |
| SLINGER, Robin | Director | 2005-01-19 | 2012-08-21 |
| THOMSON, Stephen George | Director | 1999-02-03 | 2000-04-19 |
| TURNBULL, Laurence Andrew | Director | 2006-11-23 | 2016-09-15 |
| TWOSE, Trevor Martin, Doctor | Director | 2000-11-17 | 2002-02-08 |
| WEAVER, Thomas Andrew, Dr | Director | 2007-07-03 | 2008-07-31 |
| WHEATCROFT, Russell Steven | Director | 2017-04-27 | 2021-06-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Sourcebio International Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-09-20 | Active |
Filing timeline
Last 20 of 474 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-12-07 MA Memorandum articles
- 2022-12-07 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-22 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-08-01 | AA | accounts | Accounts with accounts type full | |
| 2025-01-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-12 | AA | accounts | Accounts with accounts type full | |
| 2024-01-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-12-18 | MR05 | mortgage | Mortgage charge part both with charge number | |
| 2023-10-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-02 | TM01 | officers | Termination director company with name termination date | |
| 2023-06-10 | AA | accounts | Accounts with accounts type full | |
| 2023-05-17 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-01-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-09 | AD02 | address | Change sail address company with old address new address | |
| 2022-12-07 | MA | incorporation | Memorandum articles | |
| 2022-12-07 | RESOLUTIONS | resolution | Resolution | |
| 2022-11-24 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-09-26 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-01 | AA | accounts | Accounts with accounts type full | |
| 2022-07-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-09-17 | AA | accounts | Accounts with accounts type full | |
| 2021-07-05 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
-91.6%
£31,071,000 £2,623,000
-
Net assets
-0.3%
£20,283,000 £20,223,000
-
Employees
0%
2 2
-
Operating profit
-183.3%
-£6,000 -£17,000
-
Profit before tax
-100.9%
£19,990,000 -£187,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers